AIM
PCRX icon

AXA Investment Managers’s Pacira BioSciences PCRX Stock Holding History

AXA Investment Managers’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$3.02M Buy
+117,285
New +$2.88M 0.01% 686

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AXA Investment Managers's PCRX Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Pacira BioSciences (PCRX) in Q3 2025: 117,285 shares worth $3.02M. The stake represents 0.01% of the portfolio and ranks #686 among its holdings.

239 funds tracked by Wall St. Rank hold PCRX as of Q3 2025.

  • AXA Investment Managers held 117,285 shares of Pacira BioSciences worth $3.02M as of Q3 2025.
  • Pacira BioSciences was a new AXA Investment Managers position in Q3 2025.
  • Pacira BioSciences made up 0.01% of AXA Investment Managers's portfolio in Q3 2025, its #686 holding.
  • 239 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.